Communicating prognosis in cancer care: a systematic review of the literature von Hagerty, R. G., Butow, P. N., Ellis, P. M., Dimitry, S., Tattersall, M. H. N.

Volltext

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group s... von Laurie, S.A, Solomon, B.J, Seymour, L, Ellis, P.M, Goss, G.D, Shepherd, F.A, Boyer, M.J, Arnold, A.M, Clingan, P, Laberge, F, Fenton, D, Hirsh, V, Zukin, M, Stockler, M.R, Lee, C.W, Chen, E.X, Montenegro, A, Ding, K, Bradbury, P.A

Volltext

Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature von ELLIS, P. M

Volltext

Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review von Sun, A, Durocher-Allen, L D, Ellis, P M, Ung, Y C, Goffin, J R, Ramchandar, K, Darling, G

Volltext

Acute pancreatitis and the influence of socioeconomic deprivation von Ellis, M. P., French, J. J., Charnley, R. M.

Volltext

Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor rece... von Goodwin, R., Ding, K., Seymour, L., LeMaître, A., Arnold, A., Shepherd, F.A., Dediu, M., Ciuleanu, T., Fenton, D., Zukin, M., Walde, D., Laberge, F., Vincent, M., Ellis, P.M., Laurie, S.A.

Volltext

Antiangiogenic therapies in non-small-cell lung cancer von Alshangiti, A, Chandhoke, G, Ellis, P M

Volltext

Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to Participate von ELLIS, Peter M, BUTOW, Phyllis N, TATTERSALL, Martin H. N, DUNN, Stewart M, HOUSSAMI, Nehmat

Volltext

Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases von Ali, A, Goffin, J R, Arnold, A, Ellis, P M

Volltext

Thyroid Hormone Transport by the Heterodimeric Human System L Amino Acid Transporter von Friesema, Edith C. H, Docter, Roel, Moerings, Ellis P. C. M, Verrey, François, Krenning, Eric P, Hennemann, Georg, Visser, Theo J

Volltext

Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study von Donovan, E.K., Pond, G.R., Seow, H., Ellis, P.M., Swaminath, A.

Volltext

On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993 von Griffin, A. M., Butow, P. N., Coates, A. S., Childs, A. M., Ellis, P. M., Dunn, S. M., Tattersall, M. H. N.

Volltext

The importance of multidisciplinary team management of patients with non-small-cell lung cancer von Ellis, P M

Volltext

Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review von Ellis, P M, Coakley, N, Feld, R, Kuruvilla, S, Ung, Y C

Volltext

Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet von Ellis, P. M., Butow, P. N., Tattersall, M. H. N.

Volltext

Improved visualisation of blood while wearing KTP laser protective eyewear using digital manipulation of endoscopic images: Seventeen surgeons experience on simulation testing von Ellis, M.P., Foden, N., Han, C., Almeyda, R.

Volltext

Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy von Sun, A., Durocher-Allen, L.D., Ellis, P.M., Ung, Y.C., Goffin, J.R., Ramchandar, K., Darling, G.

Volltext

An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction von Barron, C C, Alhussein, M M, Kaur, U, Cosman, T L, Tyagi, N K, Brown, M, Mukherjee, S D, Ellis, P M, Dhesy-Thind, S, Leong, D P

Volltext

Resource use in the last three months of life by lung cancer patients in southern Ontario von Wang, Y, Van Dam, A, Slaven, M, Ellis, K J, Goffin, J R, Juergens, R A, Ellis, P M

Volltext

A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable sol... von Nehra, J., Bradbury, P. A., Ellis, P. M., Laskin, J., Kollmannsberger, C., Hao, D., Juergens, R. A., Goss, G., Wheatley-Price, P., Hotte, S. J., Gelmon, K., Tinker, A. V., Brown-Walker, P., Gauthier, I., Tu, D., Song, X., Khan, A., Seymour, Lesley, Smoragiewicz, M.

Volltext